OrganiGram Holdings Inc.

OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

OrganiGram Holdings, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.

Aurora Cannabis

SNDL Inc.

Are You Buying The Best Marijuana Stocks? 3 To Watch In 2022 The post 3 Marijuana Stocks For Your February Watchlist appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks For Your February Watchlist

Canopy Growth

Charlotte's Web Holdings, Inc.

Tilray Brands

There's a promising development in one U.S. state.

Why Marijuana Stocks Like Aurora Cannabis Rose So Much Today

HEXO Corp

Canadian marijuana stocks are reversing course Monday after last week's industrywide surge higher.

Why Canopy Growth, Hexo, and OrganiGram Are Slumping Today

CEA Industries

Leafly Holdings

WM Technology

Neptune Wellness Solutions Inc.

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is evolving as we make our way through 2022.

Catch Up On the Busiest Week For Cannabis Stocks of 2022

OrganiGram Holdings Inc OGI OGI CEO Beena Goldenberg recently spoke with Benzinga to discuss the company's ongoing growth and Q2 success. Crediting the team for persevering during the pandemic, the CEO said Organigram is focusing on utilizing its recent success to further establish itself across Canada's markets and various buyers.

Benzinga Interview: Organigram CEO Beena Goldenberg Discusses Company Performance And Canadian Cannabis Market

Cronos Group

Village Farms International

Will Canadian Pot Stocks See Upside In Q1 2022? The post Canadian Marijuana Stocks On The Nasdaq For Your Watchlist In February 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks On The Nasdaq For Your Watchlist In February 2022

The Canadian pot grower's latest numbers weren't too shabby.

Despite Market Headwinds, Organigram Is Making Progress Toward Its Goals

It has been more than three years since Canada legalized marijuana, but many producers in the country continue to struggle.

4 Eye-Popping Charts Depicting the State of the Canadian Pot Market

Top Canadian Pot Stocks To Watch In February The post Top Canadian Marijuana Stocks On The Nasdaq In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks On The Nasdaq In 2022

Sen. Schumer signals a willingness to let marijuana banking reform proceed.

Why Marijuana Stocks Are Smoking Hot Today

Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starting to hit its stride.”

Cannabis Watch: Jefferies issues bullish note on buy-rated OrganiGram, upgrades Cronos and Hexo and cuts Tilray's price target

The legal cannabis industry in Canada must continue to consolidate to make it an attractive space for investors.

This Megamerger Might Be Required Before Canadian Cannabis Stocks Can Rebound

OrganiGram enjoys its second solid quarter in a row. The company vastly improved its net loss year-over-year.

Why OrganiGram Should Generate Consistent Growth Going Forward

Curaleaf Holdings, Inc.

My 2 Top Marijuana Stock Picks for 2022

Pablo Zuanic, analyst at  Cantor Fitzgerald, offered an updated investment model for OrganiGram (TSE: OGI) (NASDAQ:OGI) for which he maintained an Overweight but lowered the 12-month price target for the stock to C$5.30 from C$5.70, owing to the increased share count. The Thesis

Model Update For OrganiGram Holdings: 'Discount To Larger Peers Is Overdone'

Flora Growth Corp

On today's Cannabis Daily host Elliot Lane looks at Value Stocks To Watch in Cannabis Space. These include: Xebra Brands (OTCPK: XBRAF)

Value Cannabis Stocks To Watch

Consecutive days of solid earnings in the Canadian cannabis sector has investors feeling better.

Why Tilray, Organigram, and Hexo Stocks Bounced Today

OrganiGram Holdings Inc. (OGI) CEO Beena Goldenberg on Q1 2022 Results - Earnings Call Transcript

OrganiGram (OGI) delivered earnings and revenue surprises of 0% and 3.44%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?

OrganiGram (OGI) Reports Q1 Loss, Tops Revenue Estimates

Organigram Holdings Inc (NASDAQ: OGI) has posted Q1 FY22 net revenue of $30.4 million, the highest quarterly net revenue in the company's history at 22% growth sequentially and 57% Y/Y. The increase was primarily due to increased adult-use recreational revenue and international revenue, partly offset by lower average selling price due to product mix and a decrease in medical revenue.

Organigram Clocks Highest Quarterly Net Revenue In Q1

Canadian cannabis company Organigram Holdings Inc. OGI, +6.79% said Tuesday it had a net loss of C$1.305 million ($1.0 million) in its fiscal first quarter to Nov. 30, narrower than the loss of C$34.3 million posted in the year-earlier period. The company did not offer a per-share breakdown in its earnings release.

Organigram tops revenue estimates in latest quarter

MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 (“Q1 Fiscal 2022”). “Our record-breaking results in the first quarter of Fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products that align with the evolving preferences of t

Organigram Reports First Quarter Fiscal 2022 Results

Top Penny Stocks To Watch In The Cannabis Sector The post Canadian Marijuana Stocks To Watch Right Now? 2 Penny Stocks For Active Traders In 2022 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Canadian Marijuana Stocks To Watch Right Now? 2 Penny Stocks For Active Traders In 2022

MONCTON, New Brunswick--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open. The Company will host a conference call to discuss its results with details as follows: Date: January 11, 2022 Time: 8:00 am Easte

Organigram to Report First Quarter Fiscal 2022 Results on January 11, 2022

OrganiGram (OGI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

News for OrganiGram Holdings Inc. Stock (OGI)